AL
Last reporting period 31 Mar, 2024
Updated —
Last price
—
Market cap $B
4.457
Exchange
XNAS - Nasdaq
5.8
Last period Current ratio
-38%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Alpine Immune
Company Analysis
ALPN valuation, rating, competitors, insights and company profile
Eyestock Rating
ALPN financial analysis by Eyestock methodology
Valuation
ALPN valuation using historical relative method
Statements
ALPN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ALPN dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Alpine Immune`s Current ratio for the last twelve months ended 2024-03-31 is 5.8
